Investigating the Domain Selectivity of Dual Inhibitors of Angiotensin I-Converting Enzyme and Neprilysin
Biochemistry · 18.11.2026
DOI: 10.1021/acs.biochem.6c00635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, online erschienen am 18.11.2026. Verfasst von Joanna Żukowska und 8 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, National Research Foundation.
Abstract (Originalsprache)
Cardiovascular diseases, driven primarily by hypertension, depend on blood pressure regulation through the renin-angiotensin-aldosterone system (RAAS), endothelin system (ES), and natriuretic peptide and kinin system (NPKS). These pathways require balanced peptide processing by enzymes such as angiotensin-converting enzyme (ACE) and neprilysin (NEP). Current antihypertensive therapies inhibit both the N-domain (nACE) and C-domain (cACE) of ACE, often causing undesirable side effects. To address this, cACE-selective inhibitors have been developed, while simultaneous inhibition of cACE and NEP has demonstrated improved pharmacological efficacy in hypertensive mice. Enzyme kinetic analyses and X-ray crystallography identified three dual cACE/NEP inhibitors (AD017, AD018, and AD019), each exhibiting approximately 10-fold selectivity for cACE over nACE. Notably, AD019 combined this cACE selectivity with low-nanomolar NEP inhibition, making it the most promising lead. These findings demonstrate that hydrophobic P1/P1′ residues and a bulky aromatic P2′ group optimally exploit the hydrophobic subsites of cACE and NEP for drug design.
Förderung
- Biotechnology and Biological Sciences Research Council
- National Research Foundation
Zitieren
APA
Żukowska, J., Cozier, G. E., Coulson, L. B., Eyermann, C. J., Basarab, G. S., Schwager, S. L., Chibale, K., Sturrock, E. D., & Acharya, K. R. (2026). Investigating the Domain Selectivity of Dual Inhibitors of Angiotensin I-Converting Enzyme and Neprilysin. Biochemistry. https://doi.org/10.1021/acs.biochem.6c00635
Vancouver
Żukowska J, Cozier GE, Coulson LB, Eyermann CJ, Basarab GS, Schwager SL, et al. Investigating the Domain Selectivity of Dual Inhibitors of Angiotensin I-Converting Enzyme and Neprilysin. Biochemistry. 2026. doi:10.1021/acs.biochem.6c00635
BibTeX
@article{Zukowska2026,
author = {Żukowska, Joanna and Cozier, Gyles E. and Coulson, Lauren B. and Eyermann, Charles J. and Basarab, Gregory S. and Schwager, Sylva L. and Chibale, Kelly and Sturrock, Edward D. and Acharya, K. Ravi},
title = {Investigating the Domain Selectivity of Dual Inhibitors of Angiotensin I-Converting Enzyme and Neprilysin},
journal = {Biochemistry},
year = {2026},
doi = {10.1021/acs.biochem.6c00635}
}
EUVIMED